JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: No intervention, Tailored counseling programs (Phase 2).
- Who it may be relevant to
- Registry conditions: Gastrointestinal Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Germany
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
JUMP\_START aims to assess the needs of individuals aged ≤ 50 years with gastrointestinal (GI) tumors and implement a tailored support and counseling program at the University Hospital Heidelberg and the National Center for Tumor Diseases (NCT). In phase 1A, 12-15 individuals aged ≤ 50 years with GI tumors will be interviewed via telephone using semi-structured interviews to obstain a detailed understanding of the life situation, the burdens, and the care situation within the structures of the NCT Heidelberg. In phase 1B, the care networks of young patients with GI tumors beyond the NCT, including the analysis of changes and important access routes/possible gatekeepers, will be explored using so-called ego-centered network analyses, in comparison with patients who received a GI tumor diagnosis after the age of 50. In response to the results of phase 1A and 1B, the care services for young patients with GI tumors will be optimized, and tailored counseling programs will be developed in phase 2. These project phases will be accompanied by Quality of Life assessments using European Organisation for Research and Treatment of Cancer (EORTC) questionnaires. All patients with GI tumors (regardless of potential inclusion in phase 1A or 1B) will receive the EORTC questionnaires once. In phase 2, Quality of Life will be assessed every 6 months.
Interventions
- Other No intervention
No intervention - Other Tailored counseling programs (Phase 2)
Optimized care services and tailored counseling programs for young patients with GI tumors at the Heidelberg University Hospital (Phase 2)
Primary outcome measures
- Change from baseline in Quality of Life at two years [Time frame: Baseline, 6; 12; 18, and 24 months]
Eligibility criteria
Inclusion criteria
- Individuals aged ≥ 18 and ≤ 50 years receiving treatment for a GI tumor at the Heidelberg University Hospital
- Sufficient knowledge of the German language
- Capable of providing informed consent
- Additional recruitment for Phase 1B and Quality of Life assessments: Patients with GI tumor aged ≥ 51 years
Exclusion criteria
- Individuals with a GI tumor diagnosis after the age of 50 (except in Phase 1B and for Quality of Life assessments)
- Individuals with a GI tumor diagnosis under the age of 18
- Lack of capacity to consent and/or absence of informed consent
- Insufficient knowledge of the German language
- Severe cognitive impairments
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Germany · 1 center
- National Center for Tumor Diseases (NCT) Heidelberg — Heidelberg
Identifiers
NCT: NCT06621277 · NCT_GI_BCK_02 · AIO-LQ-0323ass